Photo Credit: Visual Generation

The implementation of inflammatory bowel disease (IBD)-specific cognitive behavioral therapy (CBT) targeting patients with IBD with poor QOL, anxiety, and depression, demonstrated comparable and slightly larger treatment effects compared to a previous benchmark, with positive evaluations from gastroenterologists, nurses, and psychologists.

This paper describes the implementation of inflammatory bowel disease (IBD)-specific cognitive behavioural therapy (CBT) for IBD patients with poor quality of life (QoL), anxiety and depression, in four hospitals in the Netherlands.

Treatment outcomes were compared with those of a previously published randomized control trial (RCT) of ‘IBD-specific CBT’, following a benchmark strategy. Primary outcome was IBD-specific QoL (IBDQ) completed before and after CBT, secondary outcomes were anxiety and depressive symptoms (HADS, CES-D). Semi-structured interviews were conducted among a pilot of gastroenterologists, nurse specialists and psychologists to evaluate ‘IBD-specific CBT’. 94 patients started treatment (280 screened).

At follow-up, 63 participants (67% compared to 81% in the RCT benchmark) completed the IBDQ. Treatment effect sizes of the implementation study were comparable and slightly larger than those of RCT benchmark.

Gastroenterologists, IBD nurses and psychologists found CBT necessary for IBD patients with poor QoL, depression and/or anxiety disorders. ‘IBD-specific CBT’ can be successfully implemented. Regular supervision of psychologists performing ‘IBD-specific CBT’ treatment is needed.

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.